fbpx

Written by 08:00 Analys, Research

GRANGEX: Progress and project improvement against prolonged favorable macro backdrop

As a result of the ongoing preparations of the DFS for Dannemora, GRANGEX now reports an upwards revision of the known and indicated mineral resources, following a reinterpretation of the drill cores, by 990 kT to 29,176 kT. Inferred resources are also increased by 125 kT of 36.6% iron. While this signals strength with regards to cost efficient project development and how modern mining methods can add value to old projects, it has marginal effect on our fair value, where we now find support for SEK 98-168 (95-163) per share in 12-24 months. However, with a structural long-term growth in demand for green CO2 free iron ore and a prolonged supply crisis following Russia’s cut off from Europe, macro developments continue to benefit both of GRANGEX’s projects, which along with continued operational progress should benefit a revaluation of the share. 


Johan Widmark | 2022-08-10 08:00 

This commissioned research report is for informational purposes only and is to be considered marketing communication. This research report has not been prepared in accordance with legal requirements designed to promote the independence of investment research and Emergers is not subject to any prohibition on dealing ahead of the dissemination of investment research. This research does not constitute investment advice and is not a solicitation to buy shares. For more information, please refer to disclaimer.  
 
Next step DFS for Apatite in Q3 and Dannemora in Q4

In the very last days of Q2’22, after some minor delays, GRANGEX submitted the environmental permit application to the Swedish Land and Environmental court for the restart of Dannemora to produce high grade iron ore. Now the next step is to finalize the Definitive Feasibility Study (DFS) for Dannemora which we expect before the year end. In total there are 18,000 meters of drill cores that have been tested, accounting for about 50% of the relevant cores, meaning that there are more cores to test, which could changes resource estimates, and our fair value, further.

With regards to the Apatite project we expect the submission of the environmental permit application already in Q3’22 along with the DFS. With the major financing round for these projects most likely during H1’23, we maintain our projection of production start for the Apatite project around winter ‘23/24 and production start in Dannemora around winter ‘24/25.

War in Ukraine continue to offer support to prices

Iron Ore prices have seen a slight pullback from the levels seen after Russia invaded Ukraine, but remain at 130+ USD per ton. Historically, Russia has accounted for over 20% of European imports of high grade iron ore and pellets, and with no quick solution in sight, this continues to lend support to our expectation of a continued expansion of the price premium for higher grades, such as the best in class 68% quality to be produced at Dannemora.

The war in Ukraine and subsequent trade restrictions have also continued to push prices of phosphate rock further, where prices have surged to now being closer to 300 USD/t. To be prudent, we include only a small portion of these price changes into our valuation model, but note that they provide a bright backdrop for the projects which enhances GRANGX’s chances to finance the projects at attractive levels in H1’23 as well as the chances to potentially include some form of trade financing into the mix.

Significant upside based on risk adjusted DCF

While risk appetite has recovered slightly in July/August, we maintain our key model assumptions for both projects, which show a very healthy financial profile, with a NPV at SEK 3.3bn and a repayment within three years. Reduced by project financing for both the Apatite project and Dannemora, where we expect debt of SEK 650m and new equity of SEK 650m, approximately SEK 2bn remains attributable to today’s shareholders. With an estimated probability of successfully passing the next two years’ milestones of 65-85% per year, this provides support for a fair value today of around SEK 850-1,460m or SEK 98-168 per share.

Should the management decide to include a trade finance solution into the financing mix, this would probably cap some of the upside with regards to rising iron ore and/or phosphate rock prices, but also limit shareholder dilution and raise potential further.

DISCLAIMER

GENERAL DISCLAIMER AND COPYRIGHT

This commissioned research report is for informational purposes only and is to be considered marketing communication. This research does not constitute investment advice and is not a solicitation to buy shares. Information provided here or on Emergers’ website emergers.se is not intended to be financial advice. This research shall not be construed as a recommendation or solicitation to invest in the companies described. Emergers cannot be held liable for either direct or indirect damages caused by decisions made on the basis of information in this analysis. Investors are encouraged to seek additional information as well as consult a financial advisor prior to any investment decision.

This material is not intended to be financial advice. This material has been commissioned by the Company in question and prepared and issued by Emergers, in consideration of a fee payable by the Company. Emergers standard fees are SEK 240,000 pa for the production and broad dissemination of a detailed note following by regular update notes. Fees are paid upfront in cash without recourse. Emergers may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained herein represent those of the research analyst at Emergers at the time of publication. The company has been given the opportunity to influence factual statements before publication, but forecasts, conclusions and valuation reasoning are Emergers’ own. Forward-looking information or statements contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Emergers shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained in this material.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Emergers’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in this material may not be eligible for sale in all jurisdictions or to certain categories of investors. Investors are encouraged to seek additional information as well as consult a financial advisor prior to any investment decision.

Investment in securities mentioned: Emergers has a restrictive policy relating to personal dealing and conflicts of interest. Emergers does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Emergers may have a position in any or related securities mentioned in this report, subject to Emergers’ policies on personal dealing and conflicts of interest.

Copyright: Copyright 2021 Incirrata AB (Emergers)

United Kingdom
This document is prepared and provided by Emergers for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the ”FPO”) (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States
Emergers relies upon the ”publishers’ exclusion” from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Emergers does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Be first to read new research on growth stocks